New hope for hard-to-treat blood cancer patients: experimental drug shows promise
Disease control
Completed
This study tested a new drug called P1101 in 29 adults with polycythemia vera, a rare blood cancer that causes too many red blood cells. Participants were people who couldn't use standard treatments. The main goal was to see if the drug could keep blood counts normal without need…
Phase: PHASE2 • Sponsor: PharmaEssentia Japan K.K. • Aim: Disease control
Last updated May 26, 2026 12:09 UTC